StonvexLoading…
StonvexStonvexStonvexCore line items from DYAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.11M | $3.09M | $2.52M | $1.36M |
Operating Income | $-1.90M | $-7.19M | $-5.66M | $-3.73M |
Net Income | $-1.95M | $-7.36M | $-5.80M | $-1.79M |
EPS (Diluted) | $-0.05 | $-0.23 | $-0.17 | $-0.13 |
Total Assets | $7.81M | $9.95M | $11.67M | $8.14M |
Total Liabilities | $8.22M | $8.71M | $9.07M | $8.67M |
Cash & Equivalents | $4.25M | $4.62M | $5.83M | $2.14M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 36.44M | 36.19M | 36.19M | 30.14M |